Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
International Urology and Nephrology
Erschienen in: International Urology and Nephrology 7/2021

28.10.2020 | Nephrology - Review

Comparison of cardiovascular mortality in hemodialysis versus peritoneal dialysis

verfasst von: Cheng Han Ng, Zhi Hao Ong, Hersharan Kaur Sran, Teo Boon Wee

Erschienen in: International Urology and Nephrology | Ausgabe 7/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Cardiovascular disease is a significant cause of morbidity and mortality in dialysis patients. With the increasing prevalence of dialysis patients, there is a need to systematically identify the epidemiology of cardiovascular disease in hemodialysis and peritoneal dialysis patients.

Methods

A meta-analysis was conducted in reference to the MOOSE and PRISMA guidelines. Database searches were conducted on Medline and Embase on 17 March 2020. Meta-analysis of proportions was used to summarize the overall prevalence of events. Pairwise comparisons were used to compare between hemodialysis and peritoneal dialysis, and meta-regression was applied to identify the factors influencing disease.

Results

A total of 28 studies were included in the review and prevalence of cardiovascular disease events including coronary artery disease, coronary artery complications, congestive heart failure, peripheral arterial disease, atrial fibrillation, and cardiovascular mortality were summarized. Atrial fibrillation (RR 1.287 CI 1.154–1.436, p < 0.001), congestive heart failure (RR 1.229 CI 1.074–1.407, p = 0.003), and peripheral arterial disease (RR 1.132 CI 1.021–1.255, p = 0.019) were more common in hemodialysis patients, but cardiovascular mortality was lower in hemodialysis relative to peritoneal dialysis patients. (RR 0.892 CI 0.828–0.960, p = 0.002).

Conclusion

The authors have found fewer cardiovascular events but higher cardiovascular mortality in patients on PD as compared to those on HD. Future research is required to establish the causality between dialysis modality and the cardiovascular outcomes described.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Sharma S, Sarnak MJ (2017) The global burden of reduced GFR: ESRD, CVD and mortality. Nature Rev Nephrol 13(8):447–448
2.
Levin A et al (2017) Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet 390(10105):1888–1917PubMed
3.
Wolfe RA et al (1999) Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341(23):1725–1730PubMed
4.
Schold J et al (2009) Half of kidney transplant candidates who are older than 60 years now placed on the waiting list will die before receiving a deceased-donor transplant. Clin J Am Soc Nephrol 4(7):1239–1245PubMedPubMedCentral
5.
Parikh NI et al (2006) Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control. Arch Intern Med 166(17):1884–1891PubMed
6.
Johnson DW et al (2007) Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification. Nephrology (Carlton) 12(4):391–398
7.
Levin A (2003) The clinical epidemiology of cardiovascular diseases in chronic kidney disease: clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis. Semin Dial 16(2):101–105PubMed
8.
Foley RN, Parfrey PS, Sarnak MJ (1998) Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9(12 Suppl):S16-23PubMed
9.
Moher D et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097PubMedPubMedCentral
10.
Stroup DF et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting.Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283(15):2008–12PubMed
11.
Nyaga VN, Arbyn M, Aerts M (2014) Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health 72(1):39PubMedPubMedCentral
12.
Doi SA et al (2015) Advances in the meta-analysis of heterogeneous clinical trials I: The inverse variance heterogeneity model. Contemp Clin Trials 45(Pt A):130–138PubMed
13.
14.
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188PubMed
15.
Harbord RM, Higgins JPT (2008) Meta-regression in stata. Stata Jl 8(4):493–519
16.
Knapp G, Hartung J (2003) Improved tests for a random effects meta-regression with a single covariate. Stat Med 22(17):2693–2710PubMed
17.
Wan X et al (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14(1):135PubMedPubMedCentral
18.
Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5(1):13PubMedPubMedCentral
19.
Harbord RM, Egger M, Sterne JAC (2006) A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 25(20):3443–3457PubMed
20.
Wells G et al. (2000) The Newcastle–Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis
21.
Chang JH et al (2013) Hemodialysis leads to better survival in patients with diabetes or high comorbidity, compared to peritoneal dialysis. Tohoku J Exp Med 229(4):271–277PubMed
22.
Choi SR et al (2003) Comparative study of renal replacement therapy in Korean diabetic end-stage renal disease patients: a single center study. Yonsei Med J 44(3):454–462PubMed
23.
Genovesi S et al (2017) Sudden death in end stage renal disease: comparing hemodialysis versus peritoneal dialysis. Blood Purif 44(1):77–88PubMed
24.
Gentil MA et al (1991) Comparison of survival in continuous ambulatory peritoneal dialysis and hospital haemodialysis: a multicentric study. Nephrol Dial Transplant 6(6):444–451PubMed
25.
Heaf JG, Løkkegaard H, Madsen M (2002) Initial survival advantage of peritoneal dialysis relative to haemodialysis. Nephrol Dial Transplant 17(1):112–117PubMed
26.
Hou F et al (2012) China collaborative study on dialysis: a multi-centers cohort study on cardiovascular diseases in patients on maintenance dialysis. BMC Nephrol 13:94PubMedPubMedCentral
27.
Jung HY et al (2019) Dialysis modality-related disparities in sudden cardiac death: hemodialysis versus peritoneal dialysis. Kidney Res Clin Pract 38(4):490–498PubMedPubMedCentral
28.
Kayalar AO et al (2016) Comparison of Long-term Complications in Patients on Haemodialysis and Peritoneal Dialysis Longer than 10 Years. J Clin Diagn Res 10(2):05–08
29.
Kim HJ et al (2017) The pattern of choosing dialysis modality and related mortality outcomes in Korea: a national population-based study. Korean J Intern Med 32(4):699–710PubMedPubMedCentral
30.
Kim SC et al (2015) Relationship between pulmonary hypertension, peripheral vascular calcification, and major cardiovascular events in dialysis patients. Kidney Res Clin Pract 34(1):28–34PubMedPubMedCentral
31.
Lee SW et al (2019) Comparative study of peritoneal dialysis versus hemodialysis on the clinical outcomes in Korea: a population-based approach. Sci Rep 9(1):5905PubMedPubMedCentral
32.
Mehrotra R et al (2011) Serum albumin as a predictor of mortality in peritoneal dialysis: comparisons with hemodialysis. Am J Kidney Dis 58(3):418–428PubMedPubMedCentral
33.
Nader MA et al (2017) In-hospital mortality in cirrhotic patients with end-stage renal disease treated with hemodialysis versus peritoneal dialysis: a nationwide study. Perit Dial Int 37(4):464–471PubMed
34.
Niu J et al (2019) Dialysis Modality and incident atrial fibrillation in older patients with ESRD. Am J Kidney Dis 73(3):324–331PubMed
35.
Shen C-H et al (2016) Increased risk of atrial fibrillation in end-stage renal disease patients on dialysis: A nationwide, population-based study in Taiwan. Medicine 95(25):e3933–e3933PubMedPubMedCentral
36.
Weinhandl ED, Gilbertson DT, Collins AJ (2016) Mortality, hospitalization, and technique failure in daily home hemodialysis and matched peritoneal dialysis patients: a matched cohort study. Am J Kidney Dis 67(1):98–110PubMed
37.
Foley RN et al (1998) Mode of dialysis therapy and mortality in end-stage renal disease. J Am Soc Nephrol 9(2):267–276PubMed
38.
Gokal R et al (1987) OUTCOME in patients on continuous ambulatory peritoneal dialysis and haemodialysis: 4-year analysis of a prospective multicentre study. The Lancet 330(8568):1105–1109
39.
Johnson DW et al (2009) Association of dialysis modality and cardiovascular mortality in incident dialysis patients. Clin J Am Soc Nephrol CJASN 4(10):1620–1628PubMed
40.
Klinger M, Madziarska K (2019) Mortality predictor pattern in hemodialysis and peritoneal dialysis in diabetic patients. Adv Clin Exp Med 28(1):133–135PubMed
41.
Lee CC, Sun CY, Wu MS (2009) Long-term modality-related mortality analysis in incident dialysis patients. Perit Dial Int 29(2):182–190PubMed
42.
Maiorca R et al (1991) A multicenter, selection-adjusted comparison of patient and technique survivals on CAPD and hemodialysis. Perit Dial Int 11(2):118–127PubMed
43.
Quinn RR et al (2014) Impact of modality choice on rates of hospitalization in patients eligible for both peritoneal dialysis and hemodialysis. Perit Dial Int 34(1):41–48PubMedPubMedCentral
44.
Sens F et al (2011) Survival advantage of hemodialysis relative to peritoneal dialysis in patients with end-stage renal disease and congestive heart failure. Kidney Int 80(9):970–977PubMed
45.
Sharabas I, Siddiqi N (2016) Cardiovascular disease risk profiles comparison among dialysis patients. Saudi J Kidney Dis Transpl 27(4):692–700PubMed
46.
Borràs Sans M et al (2017) The modality of dialysis does not influence atheromatous vascular disease progression or cardiovascular outcomes in dialysis patients without previous cardiovascular disease. PLoS One 12(11):e0186921PubMedPubMedCentral
47.
Abuhasira R et al (2018) Atrial fibrillation characteristics in patients on haemodialysis vs peritoneal dialysis. Sci Rep 8(1):2976PubMedPubMedCentral
48.
Oguntola SO et al (2019) Atherosclerotic vascular disease is more prevalent among black ESKD patients on long-term CAPD in South Africa. BMC Nephrol 20(1):399PubMedPubMedCentral
49.
Korevaar JC et al (2003) Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. Kidney Int 64(6):2222–2228PubMed
50.
Rao NN et al (2016) The Impact of Arteriovenous Fistulae for Hemodialysis on the Cardiovascular System. Semin Dial 29(3):214–221PubMed
51.
MacRae JM et al (2004) Arteriovenous fistula-associated high-output cardiac failure: a review of mechanisms. Am J Kidney Dis 43(5):e17-22PubMed
52.
Bourquelot P (2016) Access flow reduction for cardiac failure. J Vasc Access 17(Suppl 1):S60–S63PubMed
53.
Chang TI et al (2019) Blood pressure and incident atrial fibrillation in older patients initiating hemodialysis. Clin J Am Soc Nephrol 14(7):1029–1038PubMedPubMedCentral
54.
Reinecke H et al (2009) Dilemmas in the management of atrial fibrillation in chronic kidney disease. J Am Soc Nephrol 20(4):705–711PubMed
55.
Rajagopalan S et al (2006) Peripheral arterial disease in patients with end-stage renal disease. Circulation 114(18):1914–1922PubMed
56.
Okamoto S, Iida O, Mano T (2017) Current perspective on hemodialysis patients with peripheral artery disease. Ann Vasc Dis 10(2):88–91PubMedPubMedCentral
57.
Betjes MG (2013) Immune cell dysfunction and inflammation in end-stage renal disease. Nature Rev Nephrol 9(5):255
58.
Jablonski KL, Chonchol M (2013) Vascular calcification in end-stage renal disease. Hemodialysis international. Int Symp Home Hemodialysis 17(01):17–21
59.
Termorshuizen F et al (2003) Hemodialysis and peritoneal dialysis: comparison of adjusted mortality rates according to the duration of dialysis: analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis 2. J Am Soc Nephrol 14(11):2851–2860PubMed
60.
Collins AJ et al (1999) Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis 34(6):1065–1074PubMed
61.
Schaube DE, Morrison HI, Fenton SS (1998) Comparing mortality rates on CAPD/CCPD and hemodialysis. The Canadian experience: fact or fiction? Perit Dial Int 18(5):478–84
62.
Tonelli M et al (2011) Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant 11(10):2093–2109PubMed
63.
Tang M, Li T, Liu H (2016) A comparison of transplant outcomes in peritoneal and hemodialysis patients: a meta-analysis. Blood Purif 42(2):170–176PubMed
Metadaten
Titel
Comparison of cardiovascular mortality in hemodialysis versus peritoneal dialysis
verfasst von
Cheng Han Ng
Zhi Hao Ong
Hersharan Kaur Sran
Teo Boon Wee
Publikationsdatum
28.10.2020
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 7/2021
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-020-02683-9

Weitere Artikel der Ausgabe 7/2021

International Urology and Nephrology 7/2021 Zur Ausgabe

Nephrology - Original Paper

Analysis of the prevalence and influencing factors of depression and anxiety among maintenance dialysis patients during the COVID-19 pandemic

Urology - Original Paper

Greenlight laser photoselective vaporization vs open simple prostatectomy: long-term functional outcomes after treatment of large volume prostates (> 80 cc)

Nephrology - Original Paper

Hypokalemia in peritoneal dialysis patients in Thailand: the pivotal role of low potassium intake

Urology - Original Paper

Temporal improvements in renal surgery outcomes across surgical approaches

Nephrology - Original Paper

Enhanced Bruton’s tyrosine kinase activity in the kidney of patients with IgA nephropathy

Urology - Original Paper

Association of metabolic equivalent of task (MET) score in length of stay in hospital following radical cystectomy with urinary diversion: a multi-institutional study

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise